Global Influenza A Vaccine Market Growth 2026-2032
The global Influenza A Vaccine market size is predicted to grow from US$ 8398 million in 2025 to US$ 12970 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Influenza A Vaccine Industry Forecast? looks at past sales and reviews total world Influenza A Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Influenza A Vaccine sales for 2026 through 2032. With Influenza A Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza A Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Influenza A Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Influenza A Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Influenza A Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza A Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza A Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza A Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Influenza A Vaccine Industry Forecast? looks at past sales and reviews total world Influenza A Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Influenza A Vaccine sales for 2026 through 2032. With Influenza A Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza A Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Influenza A Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Influenza A Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Influenza A Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza A Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza A Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza A Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Intramuscular Vaccine
- Nasal Spray Vaccine
- 3-18 Years Old
- Above 18 Years Old
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Sanofi
- GSK
- Medimmune
- Abbott
- Mitsubishi Tanabe Pharma
- Merck
- Sinovac Biotech
- Hualan Biological Engineering
- Changsheng Bio-Technology
- Beijing Tiantan Bio-Products
- What is the 10-year outlook for the global Influenza A Vaccine market?
- What factors are driving Influenza A Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Influenza A Vaccine market opportunities vary by end market size?
- How does Influenza A Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza A Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Influenza A Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Influenza A Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Influenza A Vaccine Segment by Type
2.2.1 Intramuscular Vaccine
2.2.2 Nasal Spray Vaccine
2.2.3 Influenza A Vaccine Sales by Type
2.2.3.1 Global Influenza A Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Influenza A Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Influenza A Vaccine Sale Price by Type (2021-2026)
2.3 Influenza A Vaccine Segment by Application
2.3.1 3-18 Years Old
2.3.2 Above 18 Years Old
2.3.3 Influenza A Vaccine Sales by Application
2.3.3.1 Global Influenza A Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Influenza A Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Influenza A Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Influenza A Vaccine Breakdown Data by Company
3.1.1 Global Influenza A Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Influenza A Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Influenza A Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Influenza A Vaccine Revenue by Company (2021-2026)
3.2.2 Global Influenza A Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Influenza A Vaccine Sale Price by Company
3.4 Key Manufacturers Influenza A Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Influenza A Vaccine Product Location Distribution
3.4.2 Players Influenza A Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INFLUENZA A VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Influenza A Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Influenza A Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Influenza A Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Influenza A Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Influenza A Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Influenza A Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Influenza A Vaccine Sales Growth
4.4 APAC Influenza A Vaccine Sales Growth
4.5 Europe Influenza A Vaccine Sales Growth
4.6 Middle East & Africa Influenza A Vaccine Sales Growth
5 AMERICAS
5.1 Americas Influenza A Vaccine Sales by Country
5.1.1 Americas Influenza A Vaccine Sales by Country (2021-2026)
5.1.2 Americas Influenza A Vaccine Revenue by Country (2021-2026)
5.2 Americas Influenza A Vaccine Sales by Type (2021-2026)
5.3 Americas Influenza A Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza A Vaccine Sales by Region
6.1.1 APAC Influenza A Vaccine Sales by Region (2021-2026)
6.1.2 APAC Influenza A Vaccine Revenue by Region (2021-2026)
6.2 APAC Influenza A Vaccine Sales by Type (2021-2026)
6.3 APAC Influenza A Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Influenza A Vaccine by Country
7.1.1 Europe Influenza A Vaccine Sales by Country (2021-2026)
7.1.2 Europe Influenza A Vaccine Revenue by Country (2021-2026)
7.2 Europe Influenza A Vaccine Sales by Type (2021-2026)
7.3 Europe Influenza A Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza A Vaccine by Country
8.1.1 Middle East & Africa Influenza A Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Influenza A Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Influenza A Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Influenza A Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Influenza A Vaccine
10.3 Manufacturing Process Analysis of Influenza A Vaccine
10.4 Industry Chain Structure of Influenza A Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Influenza A Vaccine Distributors
11.3 Influenza A Vaccine Customer
12 WORLD FORECAST REVIEW FOR INFLUENZA A VACCINE BY GEOGRAPHIC REGION
12.1 Global Influenza A Vaccine Market Size Forecast by Region
12.1.1 Global Influenza A Vaccine Forecast by Region (2027-2032)
12.1.2 Global Influenza A Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Influenza A Vaccine Forecast by Type (2027-2032)
12.7 Global Influenza A Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Influenza A Vaccine Product Portfolios and Specifications
13.1.3 Novartis Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Influenza A Vaccine Product Portfolios and Specifications
13.2.3 Sanofi Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Influenza A Vaccine Product Portfolios and Specifications
13.3.3 GSK Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Medimmune
13.4.1 Medimmune Company Information
13.4.2 Medimmune Influenza A Vaccine Product Portfolios and Specifications
13.4.3 Medimmune Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Medimmune Main Business Overview
13.4.5 Medimmune Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Influenza A Vaccine Product Portfolios and Specifications
13.5.3 Abbott Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 Mitsubishi Tanabe Pharma
13.6.1 Mitsubishi Tanabe Pharma Company Information
13.6.2 Mitsubishi Tanabe Pharma Influenza A Vaccine Product Portfolios and Specifications
13.6.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Mitsubishi Tanabe Pharma Main Business Overview
13.6.5 Mitsubishi Tanabe Pharma Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Influenza A Vaccine Product Portfolios and Specifications
13.7.3 Merck Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 Sinovac Biotech
13.8.1 Sinovac Biotech Company Information
13.8.2 Sinovac Biotech Influenza A Vaccine Product Portfolios and Specifications
13.8.3 Sinovac Biotech Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sinovac Biotech Main Business Overview
13.8.5 Sinovac Biotech Latest Developments
13.9 Hualan Biological Engineering
13.9.1 Hualan Biological Engineering Company Information
13.9.2 Hualan Biological Engineering Influenza A Vaccine Product Portfolios and Specifications
13.9.3 Hualan Biological Engineering Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Hualan Biological Engineering Main Business Overview
13.9.5 Hualan Biological Engineering Latest Developments
13.10 Changsheng Bio-Technology
13.10.1 Changsheng Bio-Technology Company Information
13.10.2 Changsheng Bio-Technology Influenza A Vaccine Product Portfolios and Specifications
13.10.3 Changsheng Bio-Technology Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Changsheng Bio-Technology Main Business Overview
13.10.5 Changsheng Bio-Technology Latest Developments
13.11 Beijing Tiantan Bio-Products
13.11.1 Beijing Tiantan Bio-Products Company Information
13.11.2 Beijing Tiantan Bio-Products Influenza A Vaccine Product Portfolios and Specifications
13.11.3 Beijing Tiantan Bio-Products Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Beijing Tiantan Bio-Products Main Business Overview
13.11.5 Beijing Tiantan Bio-Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza A Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Influenza A Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Influenza A Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Influenza A Vaccine Segment by Type
2.2.1 Intramuscular Vaccine
2.2.2 Nasal Spray Vaccine
2.2.3 Influenza A Vaccine Sales by Type
2.2.3.1 Global Influenza A Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Influenza A Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Influenza A Vaccine Sale Price by Type (2021-2026)
2.3 Influenza A Vaccine Segment by Application
2.3.1 3-18 Years Old
2.3.2 Above 18 Years Old
2.3.3 Influenza A Vaccine Sales by Application
2.3.3.1 Global Influenza A Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Influenza A Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Influenza A Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Influenza A Vaccine Breakdown Data by Company
3.1.1 Global Influenza A Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Influenza A Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Influenza A Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Influenza A Vaccine Revenue by Company (2021-2026)
3.2.2 Global Influenza A Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Influenza A Vaccine Sale Price by Company
3.4 Key Manufacturers Influenza A Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Influenza A Vaccine Product Location Distribution
3.4.2 Players Influenza A Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INFLUENZA A VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Influenza A Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Influenza A Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Influenza A Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Influenza A Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Influenza A Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Influenza A Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Influenza A Vaccine Sales Growth
4.4 APAC Influenza A Vaccine Sales Growth
4.5 Europe Influenza A Vaccine Sales Growth
4.6 Middle East & Africa Influenza A Vaccine Sales Growth
5 AMERICAS
5.1 Americas Influenza A Vaccine Sales by Country
5.1.1 Americas Influenza A Vaccine Sales by Country (2021-2026)
5.1.2 Americas Influenza A Vaccine Revenue by Country (2021-2026)
5.2 Americas Influenza A Vaccine Sales by Type (2021-2026)
5.3 Americas Influenza A Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza A Vaccine Sales by Region
6.1.1 APAC Influenza A Vaccine Sales by Region (2021-2026)
6.1.2 APAC Influenza A Vaccine Revenue by Region (2021-2026)
6.2 APAC Influenza A Vaccine Sales by Type (2021-2026)
6.3 APAC Influenza A Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Influenza A Vaccine by Country
7.1.1 Europe Influenza A Vaccine Sales by Country (2021-2026)
7.1.2 Europe Influenza A Vaccine Revenue by Country (2021-2026)
7.2 Europe Influenza A Vaccine Sales by Type (2021-2026)
7.3 Europe Influenza A Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza A Vaccine by Country
8.1.1 Middle East & Africa Influenza A Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Influenza A Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Influenza A Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Influenza A Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Influenza A Vaccine
10.3 Manufacturing Process Analysis of Influenza A Vaccine
10.4 Industry Chain Structure of Influenza A Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Influenza A Vaccine Distributors
11.3 Influenza A Vaccine Customer
12 WORLD FORECAST REVIEW FOR INFLUENZA A VACCINE BY GEOGRAPHIC REGION
12.1 Global Influenza A Vaccine Market Size Forecast by Region
12.1.1 Global Influenza A Vaccine Forecast by Region (2027-2032)
12.1.2 Global Influenza A Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Influenza A Vaccine Forecast by Type (2027-2032)
12.7 Global Influenza A Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Influenza A Vaccine Product Portfolios and Specifications
13.1.3 Novartis Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Influenza A Vaccine Product Portfolios and Specifications
13.2.3 Sanofi Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Influenza A Vaccine Product Portfolios and Specifications
13.3.3 GSK Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Medimmune
13.4.1 Medimmune Company Information
13.4.2 Medimmune Influenza A Vaccine Product Portfolios and Specifications
13.4.3 Medimmune Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Medimmune Main Business Overview
13.4.5 Medimmune Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Influenza A Vaccine Product Portfolios and Specifications
13.5.3 Abbott Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 Mitsubishi Tanabe Pharma
13.6.1 Mitsubishi Tanabe Pharma Company Information
13.6.2 Mitsubishi Tanabe Pharma Influenza A Vaccine Product Portfolios and Specifications
13.6.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Mitsubishi Tanabe Pharma Main Business Overview
13.6.5 Mitsubishi Tanabe Pharma Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Influenza A Vaccine Product Portfolios and Specifications
13.7.3 Merck Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 Sinovac Biotech
13.8.1 Sinovac Biotech Company Information
13.8.2 Sinovac Biotech Influenza A Vaccine Product Portfolios and Specifications
13.8.3 Sinovac Biotech Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sinovac Biotech Main Business Overview
13.8.5 Sinovac Biotech Latest Developments
13.9 Hualan Biological Engineering
13.9.1 Hualan Biological Engineering Company Information
13.9.2 Hualan Biological Engineering Influenza A Vaccine Product Portfolios and Specifications
13.9.3 Hualan Biological Engineering Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Hualan Biological Engineering Main Business Overview
13.9.5 Hualan Biological Engineering Latest Developments
13.10 Changsheng Bio-Technology
13.10.1 Changsheng Bio-Technology Company Information
13.10.2 Changsheng Bio-Technology Influenza A Vaccine Product Portfolios and Specifications
13.10.3 Changsheng Bio-Technology Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Changsheng Bio-Technology Main Business Overview
13.10.5 Changsheng Bio-Technology Latest Developments
13.11 Beijing Tiantan Bio-Products
13.11.1 Beijing Tiantan Bio-Products Company Information
13.11.2 Beijing Tiantan Bio-Products Influenza A Vaccine Product Portfolios and Specifications
13.11.3 Beijing Tiantan Bio-Products Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Beijing Tiantan Bio-Products Main Business Overview
13.11.5 Beijing Tiantan Bio-Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Influenza A Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Influenza A Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Intramuscular Vaccine
Table 4. Major Players of Nasal Spray Vaccine
Table 5. Global Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Influenza A Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Influenza A Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Influenza A Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Influenza A Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Influenza A Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Influenza A Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Influenza A Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Influenza A Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Influenza A Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Influenza A Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Influenza A Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Influenza A Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Influenza A Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Influenza A Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Influenza A Vaccine Producing Area Distribution and Sales Area
Table 21. Players Influenza A Vaccine Products Offered
Table 22. Influenza A Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Influenza A Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Influenza A Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Influenza A Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Influenza A Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Influenza A Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Influenza A Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Influenza A Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Influenza A Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Influenza A Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Influenza A Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Influenza A Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Influenza A Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Influenza A Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Influenza A Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Influenza A Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Influenza A Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Influenza A Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Influenza A Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Influenza A Vaccine
Table 52. Key Market Challenges & Risks of Influenza A Vaccine
Table 53. Key Industry Trends of Influenza A Vaccine
Table 54. Influenza A Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Influenza A Vaccine Distributors List
Table 57. Influenza A Vaccine Customer List
Table 58. Global Influenza A Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Influenza A Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Influenza A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Influenza A Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Influenza A Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Influenza A Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Influenza A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Influenza A Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Influenza A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Influenza A Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Influenza A Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Influenza A Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Influenza A Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Influenza A Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Novartis Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Novartis Influenza A Vaccine Product Portfolios and Specifications
Table 74. Novartis Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Novartis Main Business
Table 76. Novartis Latest Developments
Table 77. Sanofi Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi Influenza A Vaccine Product Portfolios and Specifications
Table 79. Sanofi Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Sanofi Main Business
Table 81. Sanofi Latest Developments
Table 82. GSK Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Influenza A Vaccine Product Portfolios and Specifications
Table 84. GSK Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Medimmune Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Medimmune Influenza A Vaccine Product Portfolios and Specifications
Table 89. Medimmune Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Medimmune Main Business
Table 91. Medimmune Latest Developments
Table 92. Abbott Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Influenza A Vaccine Product Portfolios and Specifications
Table 94. Abbott Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Abbott Main Business
Table 96. Abbott Latest Developments
Table 97. Mitsubishi Tanabe Pharma Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Mitsubishi Tanabe Pharma Influenza A Vaccine Product Portfolios and Specifications
Table 99. Mitsubishi Tanabe Pharma Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Mitsubishi Tanabe Pharma Main Business
Table 101. Mitsubishi Tanabe Pharma Latest Developments
Table 102. Merck Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck Influenza A Vaccine Product Portfolios and Specifications
Table 104. Merck Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. Sinovac Biotech Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Sinovac Biotech Influenza A Vaccine Product Portfolios and Specifications
Table 109. Sinovac Biotech Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Sinovac Biotech Main Business
Table 111. Sinovac Biotech Latest Developments
Table 112. Hualan Biological Engineering Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Hualan Biological Engineering Influenza A Vaccine Product Portfolios and Specifications
Table 114. Hualan Biological Engineering Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Hualan Biological Engineering Main Business
Table 116. Hualan Biological Engineering Latest Developments
Table 117. Changsheng Bio-Technology Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Changsheng Bio-Technology Influenza A Vaccine Product Portfolios and Specifications
Table 119. Changsheng Bio-Technology Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Changsheng Bio-Technology Main Business
Table 121. Changsheng Bio-Technology Latest Developments
Table 122. Beijing Tiantan Bio-Products Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Beijing Tiantan Bio-Products Influenza A Vaccine Product Portfolios and Specifications
Table 124. Beijing Tiantan Bio-Products Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Beijing Tiantan Bio-Products Main Business
Table 126. Beijing Tiantan Bio-Products Latest Developments
Table 1. Influenza A Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Influenza A Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Intramuscular Vaccine
Table 4. Major Players of Nasal Spray Vaccine
Table 5. Global Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Influenza A Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Influenza A Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Influenza A Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Influenza A Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Influenza A Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Influenza A Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Influenza A Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Influenza A Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Influenza A Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Influenza A Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Influenza A Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Influenza A Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Influenza A Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Influenza A Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Influenza A Vaccine Producing Area Distribution and Sales Area
Table 21. Players Influenza A Vaccine Products Offered
Table 22. Influenza A Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Influenza A Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Influenza A Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Influenza A Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Influenza A Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Influenza A Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Influenza A Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Influenza A Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Influenza A Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Influenza A Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Influenza A Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Influenza A Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Influenza A Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Influenza A Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Influenza A Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Influenza A Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Influenza A Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Influenza A Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Influenza A Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Influenza A Vaccine
Table 52. Key Market Challenges & Risks of Influenza A Vaccine
Table 53. Key Industry Trends of Influenza A Vaccine
Table 54. Influenza A Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Influenza A Vaccine Distributors List
Table 57. Influenza A Vaccine Customer List
Table 58. Global Influenza A Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Influenza A Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Influenza A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Influenza A Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Influenza A Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Influenza A Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Influenza A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Influenza A Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Influenza A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Influenza A Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Influenza A Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Influenza A Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Influenza A Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Influenza A Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Novartis Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Novartis Influenza A Vaccine Product Portfolios and Specifications
Table 74. Novartis Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Novartis Main Business
Table 76. Novartis Latest Developments
Table 77. Sanofi Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi Influenza A Vaccine Product Portfolios and Specifications
Table 79. Sanofi Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Sanofi Main Business
Table 81. Sanofi Latest Developments
Table 82. GSK Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Influenza A Vaccine Product Portfolios and Specifications
Table 84. GSK Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Medimmune Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Medimmune Influenza A Vaccine Product Portfolios and Specifications
Table 89. Medimmune Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Medimmune Main Business
Table 91. Medimmune Latest Developments
Table 92. Abbott Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Influenza A Vaccine Product Portfolios and Specifications
Table 94. Abbott Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Abbott Main Business
Table 96. Abbott Latest Developments
Table 97. Mitsubishi Tanabe Pharma Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Mitsubishi Tanabe Pharma Influenza A Vaccine Product Portfolios and Specifications
Table 99. Mitsubishi Tanabe Pharma Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Mitsubishi Tanabe Pharma Main Business
Table 101. Mitsubishi Tanabe Pharma Latest Developments
Table 102. Merck Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck Influenza A Vaccine Product Portfolios and Specifications
Table 104. Merck Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. Sinovac Biotech Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Sinovac Biotech Influenza A Vaccine Product Portfolios and Specifications
Table 109. Sinovac Biotech Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Sinovac Biotech Main Business
Table 111. Sinovac Biotech Latest Developments
Table 112. Hualan Biological Engineering Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Hualan Biological Engineering Influenza A Vaccine Product Portfolios and Specifications
Table 114. Hualan Biological Engineering Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Hualan Biological Engineering Main Business
Table 116. Hualan Biological Engineering Latest Developments
Table 117. Changsheng Bio-Technology Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Changsheng Bio-Technology Influenza A Vaccine Product Portfolios and Specifications
Table 119. Changsheng Bio-Technology Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Changsheng Bio-Technology Main Business
Table 121. Changsheng Bio-Technology Latest Developments
Table 122. Beijing Tiantan Bio-Products Basic Information, Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Beijing Tiantan Bio-Products Influenza A Vaccine Product Portfolios and Specifications
Table 124. Beijing Tiantan Bio-Products Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Beijing Tiantan Bio-Products Main Business
Table 126. Beijing Tiantan Bio-Products Latest Developments
LIST OF FIGURES
Figure 1. Picture of Influenza A Vaccine
Figure 2. Influenza A Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza A Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Influenza A Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Influenza A Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Influenza A Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Influenza A Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Intramuscular Vaccine
Figure 12. Product Picture of Nasal Spray Vaccine
Figure 13. Global Influenza A Vaccine Sales Market Share by Type in 2026
Figure 14. Global Influenza A Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Influenza A Vaccine Consumed in 3-18 Years Old
Figure 16. Global Influenza A Vaccine Market: 3-18 Years Old (2021-2026) & (K Units)
Figure 17. Influenza A Vaccine Consumed in Above 18 Years Old
Figure 18. Global Influenza A Vaccine Market: Above 18 Years Old (2021-2026) & (K Units)
Figure 19. Global Influenza A Vaccine Sale Market Share by Application (2025)
Figure 20. Global Influenza A Vaccine Revenue Market Share by Application in 2026
Figure 21. Influenza A Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Influenza A Vaccine Sales Market Share by Company in 2026
Figure 23. Influenza A Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Influenza A Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Influenza A Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Influenza A Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Influenza A Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Influenza A Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Influenza A Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Influenza A Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Influenza A Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Influenza A Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Influenza A Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Influenza A Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Influenza A Vaccine
Figure 73. Industry Chain Structure of Influenza A Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Influenza A Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Influenza A Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Influenza A Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Influenza A Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Influenza A Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Influenza A Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Influenza A Vaccine
Figure 2. Influenza A Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza A Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Influenza A Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Influenza A Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Influenza A Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Influenza A Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Intramuscular Vaccine
Figure 12. Product Picture of Nasal Spray Vaccine
Figure 13. Global Influenza A Vaccine Sales Market Share by Type in 2026
Figure 14. Global Influenza A Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Influenza A Vaccine Consumed in 3-18 Years Old
Figure 16. Global Influenza A Vaccine Market: 3-18 Years Old (2021-2026) & (K Units)
Figure 17. Influenza A Vaccine Consumed in Above 18 Years Old
Figure 18. Global Influenza A Vaccine Market: Above 18 Years Old (2021-2026) & (K Units)
Figure 19. Global Influenza A Vaccine Sale Market Share by Application (2025)
Figure 20. Global Influenza A Vaccine Revenue Market Share by Application in 2026
Figure 21. Influenza A Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Influenza A Vaccine Sales Market Share by Company in 2026
Figure 23. Influenza A Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Influenza A Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Influenza A Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Influenza A Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Influenza A Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Influenza A Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Influenza A Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Influenza A Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Influenza A Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Influenza A Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Influenza A Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Influenza A Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Influenza A Vaccine
Figure 73. Industry Chain Structure of Influenza A Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Influenza A Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Influenza A Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Influenza A Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Influenza A Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Influenza A Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Influenza A Vaccine Revenue Market Share Forecast by Application (2027-2032)
